Combination nonviral murine interleukin 2 and interleukin 12 gene therapy and radiotherapy for head and neck squamous cell carcinoma.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Archives of Otolaryngology - Head and Neck Surgery

• Publication date

  2005-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHOTOL.131.12.1079PMID 16365221
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Combination Nonviral Interleukin‐2 Gene Immunotherapy For Head and Neck Cancer: From Bench Top to Bedside

  2005cited by this paper
• Gene Therapy for Thyroid Cancer: Current Status and Future Prospects

  2004cited by this paper
• Effects of combined therapy with interleukin 2 and interleukin 12 gene-transfected tumor vaccine for head and neck carcinoma.

  2003cited by this paper
• Combination nonviral interleukin 2 gene therapy and external-beam radiation therapy for head and neck cancer.

  2003cited by this paper
• Cure of an established nonimmunogenic tumor, SCC VII, with a novel interleukin 12-based immunotherapy regimen in C3H mice.

  2003cited by this paper
• Combination Nonviral Cytokine Gene Therapy for Head and Neck Cancer

  2001cited by this paper
• Concurrent paclitaxel-containing regimens and thoracic radiation therapy for limited-disease small cell lung cancer.

  1999cited by this paper
• The Natural Killer T (NKT) Cell Ligand α-Galactosylceramide Demonstrates Its Immunopotentiating Effect by Inducing Interleukin (IL)-12 Production by Dendritic Cells and IL-12 Receptor Expression on NKT Cells

  1999cited by this paper
• Prodrug activation gene therapy and external beam irradiation in the treatment of prostate cancer.

  1999cited by this paper
• Cancer statistics, 1999

  1999cited by this paper
• Concurrent paclitaxel-containing regimens and thoracic radiation therapy for limited-disease small cell lung cancer.

  1999cited by this paper
• Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.

  1997cited by this paper
• A new immunocompetent murine model for oral cancer.

  1997cited by this paper
• Requirement for Vα14 NKT Cells in IL-12-Mediated Rejection of Tumors

  1997cited by this paper
• Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in Vitro and in Vivo in human renal cell carcinoma xenografts

  1997cited by this paper
• Administration of interleukin 12 with pulse interleukin 2 and the rapid and complete eradication of murine renal carcinoma.

  1996influential reference
• Interleukins 2 and 12 activate natural killer cytolytic responses of peripheral blood mononuclear cells from patients with head and neck squamous cell carcinoma.

  1996cited by this paper
• The mechanism of local tumor irradiation combined with interleukin 2 therapy in murine renal carcinoma: histological evaluation of pulmonary metastases.

  1996cited by this paper
• Radiation-induced effects on murine kidney tumor cells: role in the interaction of local irradiation and immunotherapy.

  1995cited by this paper
• Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-gamma in vivo.

  1994cited by this paper
• Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production.

  1994cited by this paper
• Cancer statistics

  1989cited by this paper

• The future of interleukin gene therapy in head and neck cancers

  2024cites this paper
• Engineering nanoparticles for cancer immunotherapy: Current achievements, key considerations and future perspectives

  2024cites this paper
• Hormetic and synergistic effects of cancer treatments revealed by modelling combinations of radio - or chemotherapy with immunotherapy

  2023influential citation
• Recent advances in the liposomal nanovesicles based immunotherapy in the treatment of cancer: A review

  2022cites this paper
• Interleukin-12 as an in situ cancer vaccine component: a review

  2022influential citation
• Immune correlates of therapy outcomes in women with cervical cancer treated with chemoradiotherapy: A systematic review

  2021cites this paper
• Nanotechnology Synergised Immunoengineering for Cancer.

  2021cites this paper
• Insights into Nanomedicine for Immunotherapeutics in Squamous Cell Carcinoma of the head and neck

  2020cites this paper
• Preparation of aluminum nitride by combustion of a Mg-Al alloy

  2019cites this paper
• Radiotherapy in Combination With Cytokine Treatment

  2019cites this paper
• Cancer nanomedicine for combination cancer immunotherapy

  2019cites this paper
• Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy

  2019cites this paper
• Stereotactic body radiation therapy and thymosin alpha-1-induced anti-tumor effects in heavily pretreated, metastatic esophageal squamous cell carcinoma patients

  2018influential citation
• Antitumor Effects of IL-12 in Preclinical Studies

  2016cites this paper
• [Radiation therapy and immunomodulation: Focus on experimental data].

  2015cites this paper
• Radiothérapie et immunomodulation : mise au point sur les données expérimentales

  2015cites this paper
• A Cytokine-Delivering Polymer Is Effective in Reducing Tumor Burden in a Head and Neck Squamous Cell Carcinoma Murine Model

  2014influential citation
• Overexpression of MDA-7/IL-24 as an anticancer cytokine in gene therapy of thyroid carcinoma

  2014cites this paper
• Radiosensitizing effect of intratumoral interleukin-12 gene electrotransfer in murine sarcoma

  2013cites this paper
• Radiosensitization of breast cancer cells by TRAIL-endostatin-targeting gene therapy.

  2013cites this paper
• Evaluation of p21 promoter for interleukin 12 radiation induced transcriptional targeting in a mouse tumor model

  2013cites this paper
• Radiation therapy and immunotherapy: implications for a combined cancer treatment.

  2013cites this paper
• Understanding the functions of tumor stroma in resistance to ionizing radiation: emerging targets for pharmacological modulation.

  2013cites this paper
• Co-transfection of dendritic cells with AFP and IL-2 genes enhances the induction of tumor antigen-specific antitumor immunity

  2012cites this paper
• A novel modular polymer platform for the treatment of head and neck squamous cell carcinoma in an animal model.

  2012cites this paper
• Detailed characterization of the early response of head-neck cancer xenografts to irradiation using (18)F-FDG-PET imaging.

  2011cites this paper
• Transferrin lipoplex-mediated suicide gene therapy of oral squamous cell carcinoma in an immunocompetent murine model and mechanisms involved in the antitumoral response

  2009cites this paper
• A Novel Modular Polymer Platform for the Treatment of Head and Neck Squamous Cell Carcinoma

  2009cites this paper
• Controlled systemic release of interleukin‐12 after gene electrotransfer to muscle for cancer gene therapy alone or in combination with ionizing radiation in murine sarcomas

  2009cites this paper
• The molecular genetics of laryngeal cancer.

  2008cites this paper
• Interleukin-12 Gene Modification Exerts Anti-Tumor Effects on Murine Mammary Sarcoma Cell Line in vivo

  2008cites this paper
• Targeted gene therapy in radiotherapy

  2008cites this paper
• Clinical applications of gene therapy in head and neck cancer.

  2007cites this paper